PTC Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell PTCT and other ETFs, options, and stocks.About PTCT
PTC Therapeutics, Inc. is a biopharmaceutical company, which focuses on the discovery, development, and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders. The company was founded by Allan Steven Jacobson and Stuart Walter Peltz on March 31, 1998 and is headquartered in Warren, NJ.
PTCT Key Statistics
Stock Snapshot
The current PTC Therapeutics(PTCT) stock price is $75.38, with a market capitalization of 6.05B. The stock trades at a price-to-earnings (P/E) ratio of 8.91.
As of 2025-12-17, PTC Therapeutics(PTCT) stock has fluctuated between $74.17 and $76.14. The current price stands at $75.38, placing the stock +1.6% above today's low and -1.0% off the high.
PTC Therapeutics(PTCT) shares are trading with a volume of 1.25M, against a daily average of 1.3M.
During the past year, PTC Therapeutics(PTCT) stock moved between $35.95 at its lowest and $87.50 at its peak.
During the past year, PTC Therapeutics(PTCT) stock moved between $35.95 at its lowest and $87.50 at its peak.
PTCT News
PTC Therapeutics Canada ULC recently announced that Health Canada approved Sephience (sepiapterin) for treating hyperphenylalaninemia in sepiapterin-responsive...
PTC Therapeutics (PTCT) has quietly become one of this year’s stronger rare disease stories, with the stock climbing about 64% year to date and nearly doubling...